This is a list of all Hematology related medical scores and algorithms with their corresponding calculator/app.
Determines a person’s possible blood groups based on those of the parents.
Determines the percentage of transferrin available that is bound to the total iron binding capacity in serum.
Estimates the mean corpuscular volume, hemoglobin content and concentration of erythrocytes.
Compares the amount of albumin proteins found in blood with that of other proteins, the globulins.
Determines the international normalized ratio to help with monitoring effectiveness of anticoagulation therapy.
Estimates the average size of the erythrocytes in a blood sample based on hematocrit and RBC count.
Compares the TC, HDL, LDL and triglyceride patient levels with normal values to determine whether there is risk for heart disease.
Determines the reticulocyte index production (RPI) based on reticulocyte count, hematocrit or hemoglobin through two different methods.
Determines the maintenance dose based on target INR, body surface area and bleeding risk factors.
Estimates the concentration of HB in erythrocytes to distinguish spherocytosis or anemia.
Estimates the average weight of Hb found on erythrocytes.
Correlates ALC with CD4 levels that are used in HIV progression monitoring.
Uses patient weight, ABV and haematocrit to estimate the lost blood allowance during surgery.
Determines the level of physiological stress based on the ratio of absolute or relative neutrophils to lymphocytes.
Determines the total number of acidophilic cells from white blood cell count and eosinophil percentage.
Determines the low-density lipoprotein levels based on cholesterol blood test results (total, HDL cholesterol levels & triglycerides).
Estimates the distribution width of RBC based on the MCV and its standard deviation.
Stratifies in-hospital patients based on their venous thromboembolism risk factors.
Helps differentiate between iron deficiency anemia and beta thalassemia from MCV and RBC values.
Estimates the quantity of blood based on child’s age group and weight.
Determines mean arterial pressure and pulse pressure from systolic and diastolic measurements.
Determines risk of DIC in patients diagnosed with thrombosis associated conditions.
Predicts risk of major bleeding in patients diagnosed with ACS, especially NSTEMI.
Corrects the pulmonary result for haemoglobin in patients with anemia.
Helps rule out venous thromboembolism (VTE) in patients of 50 years or older with suspected pulmonary embolism (PE).
Prognoses outcome and risk of complications in patients with cancer who undergo chemotherapy.
Helps with cirrhosis diagnosis based on the platelet count and AST level.
Estimates the parenteral dose of iron supplement needed to restore hemoglobin level.
Estimates the average blood pressure obtained during one cardiac cycle.
Uses BUN, sodium, glucose and ethanol values to determine the blood osmolality in mOsm/Kg.
Determines the total blood amount based on Nadler formula and computes the next recommended donation date.
Predicts chance of haemorrhage after upper GI bleeding based on hemoglobin and other risk factors.
Determines blood transfusion volume (BTV) based on infant or child’s weight, hemoglobin increment and hematocrit.
Determines the ANC during blood count to help with diagnose of neutropenic fever and other conditions.
Predicts mortality risk in patients with cerebral haemorrhage caused by stroke.
Consists of the original, revised and simplified Geneva risk predictors for pulmonary embolism (PE).
Determines the volume of blood in the body based on height and weight.
Predicts hemorrhage mortality risk based on clinical patient data.
Determines the pressure induced by proteins in blood plasma that tends to pull fluid into the capillaries.
Stratifies mortality risk in patients with cerebral bleeding.
Diagnoses reactive hemophagocytic syndrome based on clinical and laboratory data.
Predicts need for massive transfusion in the case of trauma patients.
Determines the necessity of triggering massive transfusion (MT) protocol and likelihood of administration of pRBC.
Evaluates risk of cerebral bleeding in patients treated for myocardial infarction with anticoagulation therapy.
Stratifies major bleeding risk in patients under anticoagulation therapy with Warfarin.
Predicts haemorrhage risk in case of Warfarin therapy, based on patient age, history of CVA or GI.
